Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · Real-Time Price · USD
0.2860
+0.0007 (0.25%)
Aug 15, 2025, 10:03 AM - Market open

Carisma Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-49.38-60.48-86.88-61.23-40.78-28.35
Depreciation & Amortization
2.073.352.841.890.680.45
Other Amortization
--1.282.54--
Loss (Gain) From Sale of Assets
3.33-0.030.16---
Asset Writedown & Restructuring Costs
1.290.36----
Loss (Gain) From Sale of Investments
---1.11---
Stock-Based Compensation
2.913.652.320.280.480.16
Other Operating Activities
1.935.185.656.210.831.18
Change in Accounts Payable
2-1.852.19-0.47-0.971.28
Change in Unearned Revenue
-0.66-1.43-1.0547.46--
Change in Other Net Operating Assets
-0.82-8.67-6.58-1.792.44-1.74
Operating Cash Flow
-37.34-59.92-81.18-5.12-37.33-27.01
Capital Expenditures
--0.12-1.13-4.66-1.87-0.44
Investment in Securities
--73.54-27.9--
Investing Cash Flow
0.69-0.1272.41-32.56-1.87-0.44
Long-Term Debt Issued
-0.691.1836.63--
Long-Term Debt Repaid
--2.74-2.37-0.96--
Net Debt Issued (Repaid)
-1.82-2.05-1.1935.66--
Issuance of Common Stock
0.112.431.420.11-0.02
Other Financing Activities
--31.94-2.45-0.37-
Financing Cash Flow
-1.710.3462.1833.3215.9672.26
Net Cash Flow
-38.36-59.753.41-4.36-23.2444.81
Free Cash Flow
-37.34-60.04-82.31-9.78-39.2-27.45
Free Cash Flow Margin
-346.83%-305.83%-551.71%-99.41%--
Free Cash Flow Per Share
-0.90-1.45-2.46-4.59-36.16-25.82
Cash Interest Paid
0.140.190.350.1--
Levered Free Cash Flow
-21.34-33.4-50.63-30.1-24.24-
Unlevered Free Cash Flow
-21.34-33.4-51.91-30.68-24.24-
Change in Working Capital
0.52-11.95-5.4445.21.46-0.45
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q